| 7.4 -0.08 (-1.07%) | 05-16 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 9.63 | 1-year : | 11.25 |
| Resists | First : | 8.25 | Second : | 9.63 |
| Pivot price | 7.13 |
|||
| Supports | First : | 6.92 | Second : | 6.09 |
| MAs | MA(5) : | 7.36  |
MA(20) : | 7.26 |
| MA(100) : | 8.59 |
MA(250) : | 8.67 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 64.1 |
D(3) : | 62.2 |
| RSI | RSI(14): 51.1 |
|||
| 52-week | High : | 12.94 | Low : | 5 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ AMWL ] has closed below upper band by 30.9%. Bollinger Bands are 46.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 7.56 - 7.6 | 7.6 - 7.63 |
| Low: | 7.17 - 7.21 | 7.21 - 7.24 |
| Close: | 7.34 - 7.4 | 7.4 - 7.46 |
American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care. The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, TV kits, tablets, and kiosks. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Sat, 17 May 2025
(AMWL) Investment Analysis and Advice - news.stocktradersdaily.com
Wed, 07 May 2025
All You Need to Know About American Well (AMWL) Rating Upgrade to Buy - MSN
Tue, 06 May 2025
Is American Well (AMWL) Outperforming Other Medical Stocks This Year? - Nasdaq
Fri, 02 May 2025
American Well Corporation (NYSE:AMWL) Q1 2025 Earnings Call Transcript - Insider Monkey
Fri, 02 May 2025
American Well Corp (AMWL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Fri, 02 May 2025
Amwell Reports Strong Q1 2025 Financial Results - TipRanks
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 14 (M) |
| Shares Float | 12 (M) |
| Held by Insiders | 4.4 (%) |
| Held by Institutions | 46.5 (%) |
| Shares Short | 345 (K) |
| Shares Short P.Month | 344 (K) |
| EPS | -10.14 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 18.76 |
| Profit Margin | -59.2 % |
| Operating Margin | -45.5 % |
| Return on Assets (ttm) | -19.7 % |
| Return on Equity (ttm) | -43.3 % |
| Qtrly Rev. Growth | 12.3 % |
| Gross Profit (p.s.) | 8.21 |
| Sales Per Share | 18.48 |
| EBITDA (p.s.) | -8.44 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -93 (M) |
| Levered Free Cash Flow | -9 (M) |
| PE Ratio | -0.74 |
| PEG Ratio | 0 |
| Price to Book value | 0.39 |
| Price to Sales | 0.4 |
| Price to Cash Flow | -1.14 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|